Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.
about
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldSperm and oocyte communication mechanisms controlling C. elegans fertilityWhy cancer and inflammation?The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic CancerManipulation of DNA Repair Proficiency in Mouse Models of Colorectal Cancer5-methoxyindole metabolites of L-tryptophan: control of COX-2 expression, inflammation and tumorigenesisNon-microbial approach for Helicobacter pylori as faster track to prevent gastric cancer than simple eradicationAnti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrenceVariability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectivesSulindac Inhibits Canonical Wnt Signaling by Blocking the PDZ Domain of the Protein DishevelledTumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategiesBiomarkers for enhancing the radiosensitivity of nasopharyngeal carcinomaUse of nonsteroidal anti-inflammatory drugs and risk of oral cancer: a cohort studyPathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2Ovarian epithelial cancer: a role for PGE2-synthesis and signalling in malignant transformation and progressionNSAIDs and breast cancer recurrence in a prospective cohort studyAssembly of inflammation-related genes for pathway-focused genetic analysisBeyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancersRegulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinicDissection of the transformation of primary human hematopoietic cells by the oncogene NUP98-HOXA9Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trialLymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/SalicylatesNovel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?Astragalin-induced cell death is caspase-dependent and enhances the susceptibility of lung cancer cells to tumor necrosis factor by inhibiting the NF-кB pathway.Exploratory plasma proteomic analysis in a randomized crossover trial of aspirin among healthy men and women.Targeting the tumor microenvironment.Seed in soil, with an epigenetic viewCancer inflammation and regulatory T cells.Use of acetaminophen and risk of endometrial cancer: evidence from observational studies.Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic.Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control studyCurrent concepts in colorectal cancer preventionInflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapyPolymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers.Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family RegistryBone marrow fat: linking adipocyte-induced inflammation with skeletal metastasesA review of the application of inflammatory biomarkers in epidemiologic cancer research.Cyclooxygenases: mediators of UV-induced skin cancer and potential targets for prevention.Association between nonsteroidal anti-inflammatory drug use and brain tumour risk: a meta-analysis.
P2860
Q24620628-3EA7BA8D-5E11-4E7C-828A-439724046112Q24626882-F84D1777-E386-401A-B0CA-BF35499F7B6DQ24680891-DD8DF1C6-9F73-4F86-9AD8-0DC6F9B23412Q26738873-62317110-9668-495D-889E-F4F13262044AQ26740310-85B5D8FD-B31D-4573-940E-864F9BA59C79Q26997809-8E43563F-D0A7-4E21-A113-796A8DB28581Q27006833-A41540AF-F4D3-49FD-9CC2-E4627678750DQ27010314-26582649-36FD-4340-B485-E5850C2206D3Q27012539-F11EF049-A086-4716-844D-EB85B08115FFQ27656739-CC3FBB4E-1A03-47D7-BD77-88F5FF3CED9DQ28085631-BB269DFD-2F39-44B5-8290-3BBDB2FBD51DQ28087059-4B0868B9-B8ED-494F-AC07-ABF456BCC186Q28199772-9C40B6FD-4203-4247-B646-80126AA5CAC3Q28209990-A58CEC7F-5E78-4FE1-8122-33BB1B2100A8Q28210448-51829CF4-05E3-48E1-B99D-1872911317C2Q28221965-6B8F2310-0329-4842-9A91-89BB9E6A9FAAQ28222837-A1071716-872A-496E-97D6-A50006649A03Q28743513-D89A7504-BAF9-4197-8D2F-360353A10E36Q30498812-1BE54187-0AFB-4BF6-8E01-F8CAAA817AE1Q33495581-4CC54291-C083-4D75-9640-7C7286B325A7Q33503521-08608283-7CA1-4D57-AA8A-9C113ED9FA48Q33555154-0A40644D-5F1D-4A95-9E47-DB89BE807E5DQ33664334-2CFC4ABB-1A95-4E9E-94FB-AC4FC8E0225FQ33683210-D4451B32-FB79-4C4E-9586-6B51084FF2CBQ33688881-0EF610EC-99A8-47F9-8A67-2EE3A490A7C7Q33728638-2DCEDCE2-3DE8-4156-890C-19A478B48E8BQ33736691-6E858178-FB41-4DFE-A13D-8E4A325E5C5AQ33754753-8A1D38EC-1EBD-48CD-835C-C9840049DF6BQ33796582-DE3D387F-CAB8-4508-BE24-5D492A721945Q33798506-5E711A21-C487-4FA4-82E0-16DD98EB33EEQ33801854-78527224-3FB6-4B16-A520-7948DCD6D609Q33889458-44223709-3C53-46FE-A320-0E06BB25A3B6Q34065803-6C78B5E0-0F8D-4BE5-A915-A8E1B9927312Q34076429-C575694A-5137-4A6A-8D3A-571D70FAE9F7Q34084838-FC5B8918-E30D-4DB0-8B06-7791B565FDA0Q34096843-670C7F00-3416-419D-AD10-2FD48BC6580DQ34132305-F20754C4-86F3-4CE9-B33A-E0972CA640CDQ34135803-DD5381BF-08B8-44B0-AAD2-2CCEE84D7CD5Q34195623-1975C9DA-232C-4976-9A68-6591612AC853Q34209511-FD65FB2A-1055-47C9-ADD0-A6131EC5F7AE
P2860
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Non-steroidal anti-inflammator ...... , perils and pharmacogenetics.
@ast
Non-steroidal anti-inflammator ...... , perils and pharmacogenetics.
@en
type
label
Non-steroidal anti-inflammator ...... , perils and pharmacogenetics.
@ast
Non-steroidal anti-inflammator ...... , perils and pharmacogenetics.
@en
prefLabel
Non-steroidal anti-inflammator ...... , perils and pharmacogenetics.
@ast
Non-steroidal anti-inflammator ...... , perils and pharmacogenetics.
@en
P2860
P356
P1476
Non-steroidal anti-inflammator ...... , perils and pharmacogenetics.
@en
P2093
Cornelia M Ulrich
Jeannette Bigler
P2860
P2888
P304
P356
10.1038/NRC1801
P407
P50
P577
2006-02-01T00:00:00Z
P5875
P6179
1028163103